Cargando…
Does binge-eating matter for glycemic control in type 2 diabetes patients?
BACKGROUND: Eating behavior is an important aspect related to type 2 diabetes mellitus (T2DM) treatment and may have an impact on glycemic control. Previous reports showed elevated prevalence of eating disordered behaviors, especially binge eating disorder in clinical samples of type 2 diabetes pati...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728934/ https://www.ncbi.nlm.nih.gov/pubmed/31516703 http://dx.doi.org/10.1186/s40337-019-0260-4 |
_version_ | 1783449506862333952 |
---|---|
author | Papelbaum, Marcelo de Oliveira Moreira, Rodrigo Coutinho, Walmir Ferreira Kupfer, Rosane Freitas, Silvia Raggio Luz, Ronir Appolinario, José Carlos |
author_facet | Papelbaum, Marcelo de Oliveira Moreira, Rodrigo Coutinho, Walmir Ferreira Kupfer, Rosane Freitas, Silvia Raggio Luz, Ronir Appolinario, José Carlos |
author_sort | Papelbaum, Marcelo |
collection | PubMed |
description | BACKGROUND: Eating behavior is an important aspect related to type 2 diabetes mellitus (T2DM) treatment and may have an impact on glycemic control. Previous reports showed elevated prevalence of eating disordered behaviors, especially binge eating disorder in clinical samples of type 2 diabetes patients. However, results regarding the impact of an eating disorder on the glycemic and clinical control of T2DM is inconsistent. The purpose of this study was to assess the impact of a comorbid eating disorder on glycemic control (GC) in a group of patients with T2DM. METHODS: Eating behaviors of 70 consecutive patients with T2DM were assessed using a Structured Clinical Interview for DSM-IV and the Binge Eating Scale. The GC was examined with fasting blood glucose (FBG) and glycated hemoglobin (A1c) levels. In addition, secondary clinical variables were assessed, including body mass index (BMI) and lipids. Chi-square and Student’s T tests were used to compare clinical and psychopathological characteristics of patients with and without an ED. In order to evaluate the relationship between GC and eating disorder (ED) a linear regression analysis was performed, controlling for BMI. A significance level of 5% was adopted. RESULTS: Seventy-seven percent of the sample (n = 54) were female and 50% were obese. Fourteen patients exhibited an ED, mostly binge eating disorder (BED). In a regression analysis, both FBG (beta coefficient = 47.4 (22.3); p = 0.037) and A1c (beta coefficient = 1.12 (0.57); p = 0.05) were predicted by the presence of an ED. However, the presence of an ED lost its impact on glycemic control outcomes after the addition of the BMI in the models. CONCLUSIONS: Eating psychopathology is frequently observed in patients with T2DM. Among individuals with T2DM, co-morbid ED is associated with a poorer glycemic control in the presence of a higher BMI. The presence of an eating disordered behavior in patients with T2DM seems to have clinical relevance in the usual care of patients with diabetes. Therefore, we recommend eating psychopathology should be routinely assessed in T2DM patients. |
format | Online Article Text |
id | pubmed-6728934 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-67289342019-09-12 Does binge-eating matter for glycemic control in type 2 diabetes patients? Papelbaum, Marcelo de Oliveira Moreira, Rodrigo Coutinho, Walmir Ferreira Kupfer, Rosane Freitas, Silvia Raggio Luz, Ronir Appolinario, José Carlos J Eat Disord Research Article BACKGROUND: Eating behavior is an important aspect related to type 2 diabetes mellitus (T2DM) treatment and may have an impact on glycemic control. Previous reports showed elevated prevalence of eating disordered behaviors, especially binge eating disorder in clinical samples of type 2 diabetes patients. However, results regarding the impact of an eating disorder on the glycemic and clinical control of T2DM is inconsistent. The purpose of this study was to assess the impact of a comorbid eating disorder on glycemic control (GC) in a group of patients with T2DM. METHODS: Eating behaviors of 70 consecutive patients with T2DM were assessed using a Structured Clinical Interview for DSM-IV and the Binge Eating Scale. The GC was examined with fasting blood glucose (FBG) and glycated hemoglobin (A1c) levels. In addition, secondary clinical variables were assessed, including body mass index (BMI) and lipids. Chi-square and Student’s T tests were used to compare clinical and psychopathological characteristics of patients with and without an ED. In order to evaluate the relationship between GC and eating disorder (ED) a linear regression analysis was performed, controlling for BMI. A significance level of 5% was adopted. RESULTS: Seventy-seven percent of the sample (n = 54) were female and 50% were obese. Fourteen patients exhibited an ED, mostly binge eating disorder (BED). In a regression analysis, both FBG (beta coefficient = 47.4 (22.3); p = 0.037) and A1c (beta coefficient = 1.12 (0.57); p = 0.05) were predicted by the presence of an ED. However, the presence of an ED lost its impact on glycemic control outcomes after the addition of the BMI in the models. CONCLUSIONS: Eating psychopathology is frequently observed in patients with T2DM. Among individuals with T2DM, co-morbid ED is associated with a poorer glycemic control in the presence of a higher BMI. The presence of an eating disordered behavior in patients with T2DM seems to have clinical relevance in the usual care of patients with diabetes. Therefore, we recommend eating psychopathology should be routinely assessed in T2DM patients. BioMed Central 2019-09-06 /pmc/articles/PMC6728934/ /pubmed/31516703 http://dx.doi.org/10.1186/s40337-019-0260-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Papelbaum, Marcelo de Oliveira Moreira, Rodrigo Coutinho, Walmir Ferreira Kupfer, Rosane Freitas, Silvia Raggio Luz, Ronir Appolinario, José Carlos Does binge-eating matter for glycemic control in type 2 diabetes patients? |
title | Does binge-eating matter for glycemic control in type 2 diabetes patients? |
title_full | Does binge-eating matter for glycemic control in type 2 diabetes patients? |
title_fullStr | Does binge-eating matter for glycemic control in type 2 diabetes patients? |
title_full_unstemmed | Does binge-eating matter for glycemic control in type 2 diabetes patients? |
title_short | Does binge-eating matter for glycemic control in type 2 diabetes patients? |
title_sort | does binge-eating matter for glycemic control in type 2 diabetes patients? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728934/ https://www.ncbi.nlm.nih.gov/pubmed/31516703 http://dx.doi.org/10.1186/s40337-019-0260-4 |
work_keys_str_mv | AT papelbaummarcelo doesbingeeatingmatterforglycemiccontrolintype2diabetespatients AT deoliveiramoreirarodrigo doesbingeeatingmatterforglycemiccontrolintype2diabetespatients AT coutinhowalmirferreira doesbingeeatingmatterforglycemiccontrolintype2diabetespatients AT kupferrosane doesbingeeatingmatterforglycemiccontrolintype2diabetespatients AT freitassilvia doesbingeeatingmatterforglycemiccontrolintype2diabetespatients AT raggioluzronir doesbingeeatingmatterforglycemiccontrolintype2diabetespatients AT appolinariojosecarlos doesbingeeatingmatterforglycemiccontrolintype2diabetespatients |